Ceryvyn Therapeutics Ltd (cyv) Logo

Ceryvyn Therapeutics Ltd (CYV)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CYV ASX Chart

Snapshot

Ceryvyn Therapeutics Limited (CYV, formerly Opthea Limited) is an ASX listed biopharmaceutical company which researches and develops novel therapeutic products based on targeting Vascular Endothelial Growth Factors (VEGF) C, D and R3. Since FY2014, the Company has been committed to the development of new therapies for the treatment of serious eye diseases that affect the back of the eye, or retina, and lead to vision loss. The Company's lead candidate was sozinibercept a VEGF C/D trap inhibitor being developed for use in conjunction with VEGF A inhibitors for the treatment of wet AMD and other retinal diseases.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -96.24%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,766 of 2,350
Sector Rank 169 of 244

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.245
DPS $0.00
Book Value Per Share $0.022

Broker Consensus

CYV is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Hawthorn East VIC 3123
Website www.ceryvyn.com
Registry Computershare
Auditor Deloitte Touche Tohmatsu
Date Listed -

Upcoming Calendar (Forecasted)

Date Event
01/03/2027 Report (Interim)
30/08/2027 Report (Prelim)
30/08/2027 Report (Annual)

Former Company Names

  • Circadian Technologies Limited (CIR), 11/12/2015, Opthea Limited (OPT), 08/07/2026

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CYV directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/06/26 Jeremy Levin Issued 48,000,000 $0.014 $672,000 Issue of options
15/06/26 Katherine(Kathy) Connell Buy +2,000,000 $0.015 $30,000 On-market trade

Director Interests

The current holdings of CYV directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Katherine(Kathy) Connell 30/06/2026 2,000,000 N/A 41,500,000 N/A
Jeremy Levin 30/06/2026 13,421,496 N/A 53,000,000 N/A
Lawrence Gozlan 30/06/2026 N/A N/A 45,500,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 17, 2026.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 102,994,028 7.53%
Ocelot SPV LP 96,466,591 7.05%
Jagien Nominees Pty Ltd 88,500,000 6.47%
Citicorp Nominees Pty Limited 47,437,283 3.46%
JAF Capital Pty Ltd 42,000,000 3.07%
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 36,618,607 2.68%
BHL Pension Pty Ltd <BHL Pension Fund A/C> 33,000,000 2.41%
Mr Christopher Ian Grant + Mrs Frances Josephine Grant <CIG FJG Superfund A/C> 30,000,000 2.19%
ALIAB Wealth Pty Ltd <Aliab Wealth A/C> 26,250,000 1.92%
JP Morgan Nominees Australia Pty Limited 25,553,310 1.87%
10 Bolivianos Pty Ltd 25,230,471 1.84%
Arctic Capital Investments Pty Ltd <Arctic Capital Holdings A/C> 22,500,000 1.64%
Kauai Capital Pty Ltd 20,000,000 1.46%
Flow Chainlink Pty Ltd <Crumpton Chain A/C> 18,000,000 1.32%
Jurkovic Family SF No 1 PL <Jurkovic Family S/F No1 A/C> 18,000,000 1.32%
HSBC Custody Nominees (Australia) Limited A/C 2 17,075,996 1.25%
Scintilla Strategic Investments Limited 15,000,000 1.10%
Mila Investment Co Pty Ltd <Mila Investment A/C> 14,100,000 1.03%
UBS Nominees Pty Ltd 13,364,206 0.98%
Mr Daniel Friedrich 12,125,000 0.89%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 2,369 2,678 858 1,420 615 7,940

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Ocelot SPV LP 17/08/2026 96,466,591 7.10
Jagen Nominees Pty Ltd 08/10/2026 226,549,303 16.56

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
08-10-26 Jagen Nominees Pty Ltd 56,190,969 12.45 16.56
05-10-26 Jagen Nominees Pty Ltd 23,152,875 10.76 12.45
01-10-26 Jagen Nominees Pty Ltd 14,897,746 9.66 10.76
23-06-26 Jagen Nominees Pty Ltd 132,307,713 -- 9.66
16-06-26 JAF Capital Pty Ltd 15,000,000 5.04 6.14
11-05-26 JAF Capital Pty Ltd 69,000,000 -- 5.04

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
22-06-26 JAF Capital Pty Ltd 84,000,000 6.14 --
16-06-26 The Bank of New York Mellon Corporation 87,105,313 6.37 --
16-06-26 Regal Funds Management Pty Limited 78,888,189 5.77 --
10-06-26 Regal Funds Management Pty Limited 72,949,348 11.10 5.77
05-06-26 Regal Funds Management Pty Limited 56,544,333 15.23 11.10
04-06-26 Regal Funds Management Pty Limited 86,498,895 21.56 15.23
03-06-26 Regal Funds Management Pty Limited 112,910,397 31.85 21.56
04-12-25 The Bank of New York Mellon Corporation 5,250,960 7.50 6.37

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
CYV Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.